CureVac
$2.80
24H
Market Cap
Volume
Supply
Price Chart
About CureVac - CVAC
CureVac N.V. is a global biopharmaceutical company that focuses on the development and commercialization of innovative mRNA-based therapies and vaccines for treating diseases and improving human health. Its technology platform has shown potential in developing prophylactic vaccines, therapeutic vaccines, and molecular therapies.
What are CureVac's core values and mission statement?
CureVac N.V., as a biopharmaceutical company, centers its core values on innovation, pioneering spirit, and dedication to developing transformative medicines. Their mission revolves around leveraging the therapeutic potential of messenger RNA (mRNA) to address high medical needs and provide accessible drugs and vaccines for patients and people globally.
Who founded CureVac and when?
CureVac N.V. was founded by Ingmar Hoerr, Florian von der Mülbe, Günther Jung and Hans-Georg Rammensee in 2000.
Who leads CureVac?
As of my last update, Dr. Franz-Werner Haas was the CEO of CureVac N.V. However, leadership positions can change, so for the most current information, please refer to the latest announcements from CureVac N.V.
Where is CureVac located, and what is its base country?
CureVac N.V. is headquartered in Tübingen, Germany, which is also its base country.
On which exchanges is CureVac traded?
CureVac N.V. is listed on the Nasdaq Global Select Market under the ticker symbol "CVAC."
Historical data
CureVac (CVAC) Price Live Data
The live price of CureVac (CVAC) is $2.80, with a trading volume of 668,227 in the last 24 hours. Wrapstocks updates the CVAC price in real-time. CureVac is down -1.06% in the last 24 hours. The company has a live market cap of $628,079,168.00 and a supply of 224,313,989 CVAC stocks.
CureVac (CVAC) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 5 hours and 56 minutes.
